Shared investments between research institutions and the government are essential for the health, prosperity and future of ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced a collaboration with Gabbi, a ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced a ...
Appoints Sam Raha as CEO and Mark S. Verratti as COO Effective April 30, 2025SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) - ...
SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial ...
SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial ...
Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results tomorrow after market hours. Here’s what you need to know. Myriad Genetics beat analysts’ revenue expectations by 1.3% ...
Shares of NASDAQ:MYGN opened at $14.19 on Thursday. The firm has a 50 day moving average of $13.45 and a 200-day moving average of $19.53. The stock has a market capitalization of $1.29 billion, a ...
In Chicopee, Massachusetts, a multi-day delay of 40 tons of salt based de-icer mucked up the street clean up. Several city trucks were sent earlier this week to Albany, New York, to pick up tons ...
SALT LAKE CITY — It didn't take long for Salt Lake City's mayor to name a new police chief. Salt Lake City Mayor Erin Mendenhall on Thursday named Brian Redd, executive director of the Utah ...
SALT LAKE CITY, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, has been named on the Forbes list of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results